Atlas FDA

NATRELLE SALINE BREAST IMPLANTS

FDA premarket approval P990074/S033 · decided 2016-10-07

Approval details

PMA number
P990074
Supplement
S033
Supplement type
Special (Immediate Track)
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
NATRELLE SALINE BREAST IMPLANTS
Generic name
Prosthesis, breast, inflatable, internal, saline
Applicant
Allergan
Date received
2016-09-07
Decision date
2016-10-07
Days to decision
30 days
Decision code
APPR
Product code
FWM
Advisory committee
General, Plastic Surgery
Expedited review
No
Location
Irvine, CA
Statement
Approval for adding a new mixing specification of ± 2.5 % (by weight) for theplatinum silicone catalyst (Part A) and cross-linked siloxane (Part B) weights, noting that weights vary based on the size of the production run to produce the standard dispersion (P/N 200-003) and the barrier dispersion (P/N 200-004) during the production of breast implant shells.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
NATRELLE INSPIRA Single Use Sizers for Gel Implants (K203229)Allergan2021-06-02
TrueTear Intranasal Tear Neurostimulator (K193589)Allergan2020-08-31
Natrelle 133 Plus MICROCELL Tissue Expander (K180826)Allergan2018-12-21
Natrelle 133S Tissue Expander (K182054)Allergan2018-08-29
TrueTear Intranasal Tear Neurostimulator (DEN170086)Allergan2018-05-17
SERI SURGICAL SCAFFOLD (K123128)Allergan2013-04-25